Literature DB >> 26459673

REM dream activity of insomnia sufferers: a systematic comparison with good sleepers.

Alexandra D Pérusse1, Joseph De Koninck2, Maude Pedneault-Drolet1, Jason G Ellis3, Célyne H Bastien4.   

Abstract

BACKGROUND AND
OBJECTIVE: The dream activity of patients with primary insomnia (PI) has rarely been studied, especially using in-laboratory dream collection, although dreams could be linked to their state of hyperarousal and their negative waking experiences. The objective of the study was to compare patients with PI and good sleeper controls (GSCs) in terms of dream recall frequency and dream content. PATIENTS/
METHODS: Polysomnography was recorded in 12 patients with PI and 12 GSCs (aged between 30 and 45 years) for five consecutive nights. Rapid eye movement (REM) sleep awakenings were enforced on nights 3 and 5 for dream collections.
RESULTS: The REM dream collections revealed that the groups were similar in terms of dream recall frequency (p ≤ 0.7). With respect to dream content variables, the dreams of GSCs tended to comprise more positive emotions (p = 0.06), whereas the dreams of patients with PI were characterized by more negative elements than positive ones (p = 0.001). Subjectively, GSCs characterized their dreams as being more pleasant and containing more joy, happiness, and vividness (p ≤ 0.03) than patients with PI. Finally, elevated negative dream content was associated with lower sleep efficiencies in insomnia (p = 0.004).
CONCLUSION: These results suggest that less positive emotions and greater negative content characterize the dreams of patients with PI, which is in line with their waking experiences. One potential explanation could be hyperarousal exacerbating presleep negative mentation, thus contributing to poorer sleep quality. The lack of difference in dream recall frequency is most likely due to the forced awakening "dream collection" procedure. The study of dream activity seems a promising avenue for understanding the 24-h experience of insomnia better and exploring the potential benefits of dream management techniques.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Continuity hypothesis; Dream activity; Dream content; Dream recall frequency; Hyperarousal; In-laboratory dream collection; Insomnia; REM sleep

Mesh:

Year:  2015        PMID: 26459673     DOI: 10.1016/j.sleep.2015.08.007

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  5 in total

1.  Clinical Trial Research on Mongolian Medical Warm Acupuncture in Treating Insomnia.

Authors:  Agula Bo; Lengge Si; Yuehong Wang; Lan Xiu; Rihan Wu; Yutang Li; Rigenjiya Mu; Latai Ga; Mei Miao; Fu Shuang; Yunhua Wu; Qiu Jin; Suocai Tong; Gerile Wuyun; Wurihan Guan; Rigen Mo; Sileng Hu; Lixia Zhang; Rui Peng; Lidao Bao
Journal:  Evid Based Complement Alternat Med       Date:  2016-12-05       Impact factor: 2.629

2.  The Effects of Sleep Quality on Dream and Waking Emotions.

Authors:  Francesca Conte; Nicola Cellini; Oreste De Rosa; Marissa Lynn Rescott; Serena Malloggi; Fiorenza Giganti; Gianluca Ficca
Journal:  Int J Environ Res Public Health       Date:  2021-01-07       Impact factor: 3.390

3.  Testing an early online intervention for the treatment of disturbed sleep during the COVID-19 pandemic in self-reported good and poor sleepers (Sleep COVID-19): study protocol for a randomised controlled trial.

Authors:  Olivia L Sawdon; Greg J Elder; Nayantara Santhi; Pamela Alfonso-Miller; Jason G Ellis
Journal:  Trials       Date:  2021-12-11       Impact factor: 2.279

4.  Proteomics Reveals Molecular Changes in Insomnia Patients with More Dreams.

Authors:  Tao Liu; Xingping Zhang; Guanying Wang; Xin Liu; Zhengting Liang; Xiaojuan Ren; Chen Chen; Deqi Yan; Wenhui Zhang
Journal:  Comput Math Methods Med       Date:  2022-04-08       Impact factor: 2.809

5.  Dreaming and Sleep-Related Metacognitions in Patients with Sleep Disorders.

Authors:  Michael Schredl; Claudia Schilling
Journal:  Clocks Sleep       Date:  2022-09-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.